Trials / Completed
CompletedNCT02561650
Pharmacokinetic, Bioavailability, and Safety Study of COV155 Administered in Healthy Subjects Under Fed and Fasted Conditions
An Open-Label, Randomized, Single-Dose, Three-Period Crossover Study to Evaluate the Pharmacokinetics, Bioavailability, and Safety of COV155 Administered in Normal, Healthy Subjects Under Fed (High- and Low-Fat Meal) and Fasted Conditions
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- Mallinckrodt · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
A single center, single dose, open-label, randomized, 3-period, 6-sequence, crossover study conducted in normal healthy subjects to evaluate the effect of a high- and low-fat meal on the pharmacokinetics (PK), bioavailability (BA), and safety of COV155.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | COV155 | COV155 tablets |
Timeline
- Start date
- 2011-12-01
- Primary completion
- 2011-12-01
- Completion
- 2011-12-01
- First posted
- 2015-09-28
- Last updated
- 2016-10-19
Source: ClinicalTrials.gov record NCT02561650. Inclusion in this directory is not an endorsement.